摘要
与阿尔茨海默氏病(AD)有关的痴呆的行为和精神症状(BPSD)在结构和功能方面与额颞电路和皮质异常改变有关。然而,具体的体积和脑功能的变化与BPSD的频率,程度及形态特点之间的联系并不明确。 方法:通过Pubmed/Medline,ISI,和Embase数据库检索从200年1月到2015年5月与AD患者神经影像学和BPSD变化相关的文献。符合条件的文献(n = 40)被纳入临床研究中,这些文献对具有BPSD的特点的AD患者的结构和功能神经影像学进行了评估。 结果:在大多数研究中,BPSD症状,特别是冷漠和精神被认为与体积减少以及前额叶皮层(轨道和背外侧部)、前扣带回、岛叶和颞叶(中间部分)的新陈代谢减慢有关。AD进展相关的WM腔隙被认为与抑郁症相关。 结论:证据表明BPSD的相关影像学发现对于理解非认知症状谱的重要性。和相关的影像学表现突出BPSD的重要性在广告结果的非认知症状谱的认识表明,额叶-边缘区域的结构和功能的改变可能会导致情绪的放松管制和无症状。由于这些研究结果可能是目前早期的广告的临床过程中,他们可能有相关的成像标记物的发展,可以用于诊断,疾病监测和预测的治疗反应。结果表明,额叶-边缘区域的结构和功能的改变可能会导致情绪的放松管制和无症状。由于这些研究结果可能存在于早期的AD患者的临床过程中,他们可能与可以诊断,疾病监测和治疗反应的预测的成像标记物的发展有关。
关键词: 阿尔茨海默病,认知,行为,BPSD的皮质、神经影像学、心理症状、白质。
Current Alzheimer Research
Title:Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review
Volume: 14 Issue: 1
Author(s): Gilberto Sousa Alves, André Férrer Carvalho, Luiza de Amorim de Carvalho, Felipe Kenji Sudo, José Ibiapina Siqueira-Neto and Viola Oertel-Knochel, Alina Jurcoane, Christian Knochel, Henning Boecker, Jerson Laks, Johannes Pantel
Affiliation:
关键词: 阿尔茨海默病,认知,行为,BPSD的皮质、神经影像学、心理症状、白质。
摘要: Background: Behavioral and psychological symptoms of dementia (BPSD) associated with Alzheimer's Disease (AD) have been linked to structural and functional alterations in fronto-temporal circuits and cortical abnormalities. However, little is known on how specific volumetric and functional brain changes may be associated with the frequency, severity and pattern of BPSD.
Methods: A systematic review of the literature regarding neuroimaging and BPSD changes in AD was performed through Pubmed/Medline, ISI, and EMBASE electronic databases from January 2000 to May 2015. Eligible references (n=40) included clinical studies in which structural or functional neuroimaging assessment was performed in AD subjects presenting BPSD features. Results: BPSD symptoms, particularly apathy and psychosis have been associated in most of studies with either volume reductions or decreased metabolism in the prefrontal cortex (orbital and dorsolateral portions), anterior cingulate, insula and temporal lobes (middle portion). WM lacunes associated with AD progression have been associated with depressive symptoms. Conclusion: The sum of evidence highlights the importance of BPSD-related imaging findings for the understanding of the non-cognitive symptom spectrum in AD. Results suggest that structural and functional changes in fronto-limbic areas may lead to emotional deregulation and symptom unawareness. As these findings may be present early on the AD clinical course, they may have a relevance for the development of imaging markers that could be used in diagnosis, disease monitoring and prediction of therapeutic response.Export Options
About this article
Cite this article as:
Gilberto Sousa Alves, André Férrer Carvalho, Luiza de Amorim de Carvalho, Felipe Kenji Sudo, José Ibiapina Siqueira-Neto and Viola Oertel-Knochel, Alina Jurcoane, Christian Knochel, Henning Boecker, Jerson Laks, Johannes Pantel , Neuroimaging Findings Related to Behavioral Disturbances in Alzheimer's Disease: A Systematic Review, Current Alzheimer Research 2017; 14 (1) . https://dx.doi.org/10.2174/1567205013666160603010203
DOI https://dx.doi.org/10.2174/1567205013666160603010203 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science The Importance of Citicoline in Combined Treatment in Dementia: What did the Citimem Study Teach us?
Reviews on Recent Clinical Trials Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration
Current Genomics The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review
Protein & Peptide Letters Meet Our Editorial Board Member
Current Neuropharmacology Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natur a l Substitutes
Current Pharmaceutical Design Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy
Current Pharmaceutical Design Pharmacological Effects of Turmeric on Learning, Memory and Expression of Muscarinic Receptor Genes (M1, M3 and M5) in Stress-induced Mouse Model
Current Drug Targets Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
Current Protein & Peptide Science Lack of Association between Genetic Polymorphism of Circadian Genes (PER2, PER3, CLOCK and OX2R) with Late Onset Depression and Alzheimer's Disease in a Sample of a Brazilian Population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease)
Current Alzheimer Research Amyloid Aggregation Inhibitory Mechanism of Arginine-rich D-peptides
Current Medicinal Chemistry The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery Promising Therapies in Sickle Cell Disease
Cardiovascular & Hematological Disorders-Drug Targets New Insights into Serotonin 5-HT4 Receptors : A Novel Therapeutic Target for Alzheimers Disease?
Current Alzheimer Research